Cargando…
Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
Alopecia areata (AA) is an autoimmune condition that causes patchy hair loss, affecting up to 147 million people globally. Currently, there are no treatments approved by US Food and Drug Administration (FDA) specific for AA, and there are few effective therapeutic options for widespread and persiste...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8860347/ https://www.ncbi.nlm.nih.gov/pubmed/35210753 http://dx.doi.org/10.2147/DDDT.S334727 |